パーキンソン病治療の世界市場見通し2017-2026

【英語タイトル】Parkinson'S Disease Treatment - Global Market Outlook (2017-2026)

Stratistics MRCが出版した調査資料(SMRC803010)・商品コード:SMRC803010
・発行会社(調査会社):Stratistics MRC
・発行日:2018年3月
・ページ数:要問い合わせ
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、パーキンソン病治療の世界市場について調査・分析し、パーキンソン病治療の世界市場規模、市場動向、セグメント別市場分析、市場環境分析、関連企業情報などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・市場動向分析
・市場環境分析(ポーターのファイブフォース分析)
・パーキンソン病治療の世界市場規模:薬効分類別分析
・パーキンソン病治療の世界市場規模:医療機器別分析
・パーキンソン病治療の世界市場規模:患者ケア設定別分析
・パーキンソン病治療の世界市場規模:流通チャンネル別分析
・パーキンソン病治療の世界市場規模:地域別分析
・主要な市場開発
・企業プロファイル
【レポートの概要】

According to Stratistics MRC, the Global Parkinson’S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%. Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period. However, availability of other treatments is hindering the market growth.

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment. Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period. This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited.

Therapeutic Class:
• Monoamine oxidase B inhibitors (MAO-B inhibitors)
• Dopamine precursors
• Dopamine agonists (non-ergoline)
• Catechol-O-methyl transferase (COMT) inhibitors
• Carbidopa/Levodopa
• Other Therapeutic Classes

Medical Devices:
• Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
• Deep Brain Stimulation (DBS) Devices

Patient Care Setting:
• Hospitals
• Clinics

Distribution Channel:
• Retail pharmacies
• Online pharmacies
• Hospital pharmacies
• Drug stores

Regions Covered:

North America
US
Canada
Mexico
Europe
Germany
UK
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Parkinson’S Disease Treatment Market, By Therapeutic Class
5.1 Introduction
5.2 Monoamine oxidase B inhibitors (MAO-B inhibitors)
5.2.1 Rasagiline
5.2.2 Selegiline
5.3 Dopamine precursors
5.3.1 Primidone
5.3.2 Phenobarbital
5.4 Dopamine agonists (non-ergoline)
5.4.1 Ropinirole
5.4.2 Pramipexole
5.4.3 Others (apomorphine and rotigotine)
5.5 Catechol-O-methyl transferase (COMT) inhibitors
5.5.1 Tolcapone
5.5.2 Entacapone
5.6 Carbidopa/Levodopa
5.7 Other Therapeutic Classes
5.7.1 Amantadine and Anticholinergic

6 Global Parkinson’S Disease Treatment Market, By Medical Devices
6.1 Introduction
6.2 Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
6.3 Deep Brain Stimulation (DBS) Devices

7 Global Parkinson’S Disease Treatment Market, By Patient Care Setting
7.1 Introduction
7.2 Hospitals
7.3 Clinics

8 Global Parkinson’S Disease Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Retail pharmacies
8.3 Online pharmacies
8.4 Hospital pharmacies
8.5 Drug stores

9 Global Parkinson’S Disease Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Leading Companies
11.1 GlaxoSmithKline Plc.
11.2 Abbvie
11.3 Acadia
11.4 Boehringer Ingelheim
11.5 Daiichi Sankyo
11.6 Impax Laboratories, Inc.
11.7 Lundbeck
11.8 Merck
11.9 Novartis
11.10 Salix Pharmaceuticals
11.11 Sun Pharma
11.12 Teva Pharmaceutical Industries Ltd.
11.13 UCB
11.14 Valeant Pharmaceuticals
11.15 Wockhardt Limited

List of Tables
1 Global Parkinson’S Disease Treatment Market By Region, Market Forecast (2016-2026) (US $MN)
2 Global Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
3 Global Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
4 Global Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
5 Global Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
6 Global Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
7 Global Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
8 Global Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
9 Global Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
10 Global Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
11 Global Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
12 Global Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
13 Global Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
14 Global Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
15 Global Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
16 Global Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
17 Global Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
18 Global Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
19 Global Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
20 Global Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
21 Global Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
22 Global Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
23 Global Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
24 Global Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
25 Global Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
26 Global Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
27 Global Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
28 Global Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
29 Global Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
30 North America Parkinson’S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
31 North America Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
32 North America Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
33 North America Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
34 North America Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
35 North America Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
36 North America Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
37 North America Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
38 North America Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
39 North America Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
40 North America Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
41 North America Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
42 North America Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
43 North America Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
44 North America Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
45 North America Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
46 North America Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
47 North America Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
48 North America Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
49 North America Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
50 North America Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
51 North America Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
52 North America Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
53 North America Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
54 North America Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
55 North America Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
56 North America Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
57 North America Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
58 North America Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
59 Europe Parkinson’S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
60 Europe Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
61 Europe Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
62 Europe Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
63 Europe Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
64 Europe Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
65 Europe Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
66 Europe Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
67 Europe Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
68 Europe Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
69 Europe Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
70 Europe Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
71 Europe Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
72 Europe Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
73 Europe Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
74 Europe Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
75 Europe Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
76 Europe Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
77 Europe Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
78 Europe Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
79 Europe Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
80 Europe Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
81 Europe Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
82 Europe Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
83 Europe Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
84 Europe Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
85 Europe Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
86 Europe Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
87 Europe Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
88 Asia Pacific Parkinson’S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
89 Asia Pacific Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
90 Asia Pacific Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
91 Asia Pacific Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
92 Asia Pacific Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
93 Asia Pacific Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
94 Asia Pacific Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
95 Asia Pacific Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
96 Asia Pacific Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
97 Asia Pacific Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
98 Asia Pacific Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
99 Asia Pacific Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
100 Asia Pacific Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
101 Asia Pacific Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
102 Asia Pacific Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
103 Asia Pacific Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
104 Asia Pacific Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
105 Asia Pacific Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
106 Asia Pacific Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
107 Asia Pacific Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
108 Asia Pacific Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
109 Asia Pacific Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
110 Asia Pacific Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
111 Asia Pacific Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
112 Asia Pacific Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
113 Asia Pacific Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
114 Asia Pacific Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
115 Asia Pacific Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
116 Asia Pacific Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
117 South America Parkinson’S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
118 South America Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
119 South America Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
120 South America Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
121 South America Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
122 South America Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
123 South America Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
124 South America Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
125 South America Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
126 South America Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
127 South America Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
128 South America Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
129 South America Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
130 South America Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
131 South America Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
132 South America Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
133 South America Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
134 South America Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
135 South America Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
136 South America Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
137 South America Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
138 South America Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
139 South America Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
140 South America Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
141 South America Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
142 South America Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
143 South America Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
144 South America Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
145 South America Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
146 Middle East & Africa Parkinson’S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
147 Middle East & Africa Parkinson’S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
148 Middle East & Africa Parkinson’S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
149 Middle East & Africa Parkinson’S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
150 Middle East & Africa Parkinson’S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
151 Middle East & Africa Parkinson’S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
152 Middle East & Africa Parkinson’S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
153 Middle East & Africa Parkinson’S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
154 Middle East & Africa Parkinson’S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
155 Middle East & Africa Parkinson’S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
156 Middle East & Africa Parkinson’S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
157 Middle East & Africa Parkinson’S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
158 Middle East & Africa Parkinson’S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
159 Middle East & Africa Parkinson’S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
160 Middle East & Africa Parkinson’S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
161 Middle East & Africa Parkinson’S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
162 Middle East & Africa Parkinson’S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
163 Middle East & Africa Parkinson’S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
164 Middle East & Africa Parkinson’S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
165 Middle East & Africa Parkinson’S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
166 Middle East & Africa Parkinson’S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
167 Middle East & Africa Parkinson’S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
168 Middle East & Africa Parkinson’S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
169 Middle East & Africa Parkinson’S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
170 Middle East & Africa Parkinson’S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
171 Middle East & Africa Parkinson’S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
172 Middle East & Africa Parkinson’S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
173 Middle East & Africa Parkinson’S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
174 Middle East & Africa Parkinson’S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)



★調査レポート[パーキンソン病治療の世界市場見通し2017-2026] (コード:SMRC803010)販売に関する免責事項を必ずご確認ください。
★調査レポート[パーキンソン病治療の世界市場見通し2017-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆